NON-INVASIVE QUANTITATIVE CT PERFUSION OF THE LIVER IN AUTOIMMUNE HEPATITIS

G Battalova1, Y Kalshabay2, Z Zholdybay3

  • 11Asfendiyarov Kazakh National Medical University, Almaty city; 2National Scientific Center of Surgery named after A.N. Syzganov, Almaty city, The Republic of Kazakhstan.

Georgian Medical News
|February 13, 2026
PubMed

Insights

Computed tomography (CT) perfusion reveals increased arterial flow (AF) and reduced portal flow (PF) in autoimmune hepatitis (AIH). These hemodynamic changes, evident even in early fibrosis, can serve as non-invasive markers for AIH liver injury.

Area of Science:

  • Hepatology
  • Radiology
  • Medical Imaging

Background:

  • Computed tomography (CT) perfusion is a non-invasive method for assessing liver hemodynamics.
  • Evidence for CT perfusion in autoimmune hepatitis (AIH) is limited compared to viral hepatitis.
  • AIH-related liver injury can lead to significant hemodynamic alterations.

Purpose of the Study:

  • To compare CT perfusion parameters (arterial flow [AF], portal flow [PF], perfusion index [PI]) in patients with AIH-related fibrosis and cirrhosis versus healthy controls.
  • To evaluate the potential of CT perfusion parameters as non-invasive markers of AIH severity.

Main Methods:

  • A single-center prospective study included 21 patients with AIH-fibrosis, 17 with AIH-cirrhosis, and 20 healthy liver donors.
  • CT perfusion parameters (AF, PF, PI) were calculated for all participants.
  • Histological staging (F1-F4) and inflammatory activity grading (A1-A4) were performed.

Main Results:

  • Arterial flow (AF) was significantly elevated in both AIH-fibrosis and AIH-cirrhosis groups compared to controls (p<0.001).
  • Portal flow (PF) was significantly reduced in both AIH-fibrosis and AIH-cirrhosis groups compared to controls (p<0.001).
  • AF and PF showed 95% sensitivity in differentiating AIH patients from controls, with no significant difference between fibrosis and cirrhosis stages.

Conclusions:

  • Increased AF and reduced PF are detectable even at the fibrosis stage of AIH.
  • These hemodynamic changes may serve as valuable non-invasive biomarkers for assessing the severity of AIH-related liver injury.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
210
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.9K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
281
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.4K
Radiological Investigation I: X-ray and CT01:30

Radiological Investigation I: X-ray and CT

Radiological investigations, including X-rays and computed tomography (CT) scans, are critical for diagnosing and evaluating various medical conditions. These imaging techniques provide valuable insights into the body's internal structures, aiding in the detection of abnormalities, assessment of disease progression, and development of treatment strategies. This article delves into two primary radiological investigations, chest X-rays and CT scans, outlining their purpose, procedures, and...
1.2K
Imaging Studies I: CT and MRI01:14

Imaging Studies I: CT and MRI

Introduction: MRI and CT scans are crucial advancements in medical imaging techniques, playing a vital role in diagnosing conditions related to the gastrointestinal (GI) system. Each scan serves distinct purposes, targets specific areas, and requires unique nursing duties.
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
940